Cases & Deals

ArunA Biomedical issues $5.3 million of Common Stock in Reg D offering

Clients ArunA Biomedical, Inc.

Jones Day advised ArunA Biomedical, Inc., a manufacturer of technologies in human stem cell research for use in drug discovery and development, in connection with its issuance of $5.3 million of Common Stock in a Regulation D offering.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.